MYOZYME

Google image searchProduct monograph

Active ingredient

alglucosidase alfa, 50 MG/VIAL

DIN: 02284863

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Schedule: Prescription

Company: SANOFI-AVENTIS CANADA INC

Date: 17-MAY-2024

ATC:

• A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
• A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
• A16AB — Enzymes (ATC, ATC/DDD)
• A16AB07 — ALGLUCOSIDASE ALFA (ATC/DDD)

Reference brand drug: Myozyme

External Links for Myozyme

Search on Google

• Myozyme side effects
• Myozyme dosage
• alglucosidase alfa side effects
• alglucosidase alfa dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find myozyme photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.